E. Anderson Et Al. , "Reactogenicity and safety of ChAd155-vectored respiratory syncytial virus (RSV) vaccine (ChAd155-RSV) administered at different dose levels in infants aged 6–7 months," 39th Annual Meeting of the European Society of Paediatric Infectious Diseases (ESPID) , Cenevre, Switzerland, 2021
Anderson, E. Et Al. 2021. Reactogenicity and safety of ChAd155-vectored respiratory syncytial virus (RSV) vaccine (ChAd155-RSV) administered at different dose levels in infants aged 6–7 months. 39th Annual Meeting of the European Society of Paediatric Infectious Diseases (ESPID) , (Cenevre, Switzerland).
Anderson, E., Baquero Artigao, F., D Boucher, F., Campbell, J. D., Castelli Gattinara, G., ÇETİN, B. Ş., ... Díez-Domingo, J.(2021). Reactogenicity and safety of ChAd155-vectored respiratory syncytial virus (RSV) vaccine (ChAd155-RSV) administered at different dose levels in infants aged 6–7 months . 39th Annual Meeting of the European Society of Paediatric Infectious Diseases (ESPID), Cenevre, Switzerland
Anderson, Evan Et Al. "Reactogenicity and safety of ChAd155-vectored respiratory syncytial virus (RSV) vaccine (ChAd155-RSV) administered at different dose levels in infants aged 6–7 months," 39th Annual Meeting of the European Society of Paediatric Infectious Diseases (ESPID), Cenevre, Switzerland, 2021
Anderson, Evan Et Al. "Reactogenicity and safety of ChAd155-vectored respiratory syncytial virus (RSV) vaccine (ChAd155-RSV) administered at different dose levels in infants aged 6–7 months." 39th Annual Meeting of the European Society of Paediatric Infectious Diseases (ESPID) , Cenevre, Switzerland, 2021
Anderson, E. Et Al. (2021) . "Reactogenicity and safety of ChAd155-vectored respiratory syncytial virus (RSV) vaccine (ChAd155-RSV) administered at different dose levels in infants aged 6–7 months." 39th Annual Meeting of the European Society of Paediatric Infectious Diseases (ESPID) , Cenevre, Switzerland.
@conferencepaper{conferencepaper, author={Evan Anderson Et Al. }, title={Reactogenicity and safety of ChAd155-vectored respiratory syncytial virus (RSV) vaccine (ChAd155-RSV) administered at different dose levels in infants aged 6–7 months}, congress name={39th Annual Meeting of the European Society of Paediatric Infectious Diseases (ESPID)}, city={Cenevre}, country={Switzerland}, year={2021}}